ICU Medical (ICUI) Tops Q4 EPS by 31c, Offers Guidance
Get Alerts ICUI Hot Sheet
Price: $97.76 +1.43%
EPS Growth %: +319.5%
Financial Fact:
Selling, general and administrative: 22.36M
Today's EPS Names:
SFST, VLTO, CLIR, More
EPS Growth %: +319.5%
Financial Fact:
Selling, general and administrative: 22.36M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.94, $0.31 better than the analyst estimate of $1.63. Revenue for the quarter came in at $315.5 million versus the consensus estimate of $295.7 million.
GUIDANCE:
ICU Medical sees FY2020 EPS of $6.50-$7.20, versus the consensus of $7.21.
For the Fiscal Year 2020, the Company expects adjusted EBITDA to be in the range of $240 million to $260 million, and adjusted diluted EPS to be in the range of $6.50 to $7.20.
For earnings history and earnings-related data on ICU Medical (ICUI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- Texas Instruments (TXN) jumps as on earnings, revenue beat in fiscal Q1
- Veralto Corporation (VLTO) Tops Q1 EPS by 6c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!